Toprun Total Solution (Ticker: 336680.KS) is an electronic components manufacturing company based in South Korea, specializing in OLED devices, plastic injection, and electronic circuit modules.

The company will list on KOSDAQ on November 1, 2024. The IPO, managed by KB Securities, aims to raise approximately $32.40 million. Top Run Total Solutions serves major clients such as LG Electronics, Hyundai, and KIA, and operates multiple domestic and international subsidiaries.

T.S. Lines Limited (Ticker: 2510.HK) is a container shipping company focused on the Asia Pacific region. The company will list its shares on the Hong Kong Stock Exchange (HKEX) on November 1, 2024.

The offering, managed by China Merchants Securities (HK) Co., Limited and J.P. Morgan Securities (Far East) Limited, aims to raise approximately $129.18 million. T.S. Lines is valued at around $849.88 million at the offer.

Sungwoo (Ticker: 458650.KS) is a company engaged in the manufacturing of LCD display panels used in various electronic products.

Sungwoo will list on October 31, 2024, on the KOSDAQ market. The firm is offering 3,000,000 shares entirely through the issuance of new shares, at an expected price range of KRW 25,000 to 29,000 per share. The total offer size is KRW 75 billion (USD 55.56 million). The offering is managed by Korea Investment & Securities.

Beijing Biostar Pharmaceuticals Co., Ltd. (Ticker: 2563.HK) is a biotechnology company focused on developing synthetic biology-driven innovative oncology drugs. The company will list its H-shares on the Hong Kong Stock Exchange (HKEX) on October 31, 2024.

The offering is managed by CCB International Capital Limited and China Securities (International) Corporate Finance Company Limited. The company is raising approximately $35.67 million through this IPO, which values it at around $891.50 million.

Jiangsu Lopal Tech. Co., Ltd. (Ticker: 2465.HK) is a new energy materials company specializing in the production of LFP (lithium iron phosphate) cathode materials and automotive specialty chemicals in mainland China. The company will list on the Hong Kong Stock Exchange (HKEX) on October 30, 2024.

The firm is offering 10,000,000 shares, representing 10.0% of the total offer shares, with a price range of HKD 4.50 to HKD 7.00 per share. The estimated market capitalization at the time of the offer ranges from HKD 2.99 billion to HKD 4.66 billion (USD 382 million to USD 594 million). The total offer size is HKD 574 million (USD 74 million). Halcyon Capital Limited and Guotai Junan Capital Limited are the sponsors, with underwriting led by Guotai Junan Securities (Hong Kong) Limited and others.

Applied Nutrition Plc (Ticker: APN LN) is a UK-based nutrition company known for its protein shakes, powders, and dietary supplements, primarily focused on muscle-building and wellness. Founded in 2014 by former scaffolder Tom Ryder, the company has become one of London’s significant IPOs of 2024.

Applied Nutrition listed on October 24, 2024, in conditional trading, with unconditional trading commencing on October 29, 2024, on the London Stock Exchange. The IPO priced at 140 pence per share, raising £157.5 million (USD 204 million) and valuing the company at approximately £350 million. Deutsche Numis managed the offering as the sole sponsor, with cornerstone and major investors including Abrdn Plc, JPMorgan Asset Management, Slater Investments, Polar Capital, and Baillie Gifford & Co.

Waaree Energies Limited, a solar photovoltaic module manufacturer, will list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on October 28, 2024.

The IPO aimed to raise approximately $514.14 million and received significant investor interest, being oversubscribed 76.34 times. The qualified institutional buyers (QIBs) portion was subscribed over 208 times, while retail and non-institutional categories saw subscriptions of 10.79 and 62.48 times, respectively. Shares will be credited to investors' demat accounts on the listing date, with refunds processed for non-allottees the same day.

OQ Exploration and Production (OQEP) is the exploration and production arm of Oman’s state oil group. The company raised $2.03 billion from its IPO, pricing shares at the top of its 370-390 baiza range. OQEP is floating around 2 billion shares, representing 25% of the company. The offering was oversubscribed by about 2.7 times, including participation from anchor investors. The listing, part of Oman’s privatization strategy, will give OQEP a market capitalization of approximately $8.1 billion.

Shares are expected to begin trading on the Muscat Stock Exchange on or around October 28, 2024.

Clobot (Ticker: 466100) is a South Korean service robot software company specializing in autonomous navigation and integrated control systems for various robot applications. Founded in 2017 by researchers from the Korea Institute of Science and Technology, Clobot's key products include Chameleon, a software for indoor navigation, and CROMS, a control system for managing different robot types. The company serves over 130 clients, including Hyundai Motor and Boston Dynamics, and is expanding into a Robot-as-a-Service (RaaS) model.

Clobot will list on the KOSDAQ on October 28, 2024, offering 3 million shares at KRW 13,000 per share to raise approximately KRW 39 billion (USD 28.34 million). The IPO is managed by Mirae Asset Securities and Shinyoung Securities. The expected market capitalization post-listing is around KRW 311.4 billion. The funds raised will be used to enhance Clobot's software solutions and develop new robotic services, including logistics and specialized cleaning robots.

Septerna, Inc. (Ticker: SEPN) is a pharmaceutical company focused on developing oral small molecule drugs targeting G protein-coupled receptors (GPCRs) for various therapeutic areas. The company’s lead candidate, SEP-876, is designed to treat hypoparathyroidism (a rare endocrine disorder where the body produces insufficient parathyroid hormone, leading to low calcium levels) and is currently in Phase 1 clinical trials. Septerna also has programs targeting chronic spontaneous urticaria (CSU, a skin condition causing recurring hives and swelling) and other mast cell diseases, as well as Graves' disease (an autoimmune disorder causing hyperthyroidism) and thyroid eye disease (TED, a condition causing inflammation and swelling behind the eyes, often related to Graves' disease).

WeRide Inc. (Ticker: WRD) is a Chinese autonomous driving technology company that develops and operates self-driving vehicles across 30 cities in seven countries, including China, the U.S., the UAE, and Singapore.

The company is set to price its Nasdaq listing on Thursday, with trading expected on Friday, August 16, offering 6.45 million American Depositary Receipts (ADRs) at a price range of $15.50 to $18.50 each. These ADRs represent approximately 2% of WeRide's enlarged share capital.

The IPO, led by Morgan Stanley, JP Morgan, and CICC, aims to raise $119 million, with Germany's Bosch expressing interest in purchasing nearly all the shares, amounting to $100 million. Concurrently, a private placement will raise $320.5 million from investors, including the Renault Nissan Mitsubishi Alliance. WeRide's revenue for the first half of 2024 was $21 million, a decrease of 18% year-over-year, with an adjusted net loss of RMB 316 million ($43.6 million).

Rigaku Corporation (Ticker: TBD) is a Japanese manufacturer of X-ray testing tools. The company, backed by Carlyle Group, will list on the Tokyo Stock Exchange on October 25, 2024. Rigaku is offering shares to raise up to 126.1 billion yen (USD 876 million), including an overallotment option.

The expected market capitalization at the time of the offering is 284.1 billion yen (USD 1.98 billion). Carlyle Group's shareholding in Rigaku will drop from 75.5% to 40.7% post-IPO. The offering is managed by Bank of America, JPMorgan, Morgan Stanley, and Nomura.

Ingram Micro Holding Corp. (Ticker: INGM) is a global technology distributor that provides products and services from over 1,500 vendors to more than 161,000 clients across 57 countries. The company distributes a wide range of technology products, including smartphones, computers, and cloud-based solutions.

Ingram Micro will list on the NYSE on October 24, 2024. The company is offering 18.6 million shares at a price range of $20.00 to $23.00, aiming to raise approximately $399.9 million. The expected market capitalization at offer is $5.06 billion. The offering is managed by Morgan Stanley, Goldman Sachs, and J.P. Morgan, among others. Platinum Equity, the majority shareholder, will retain a 90.8% stake post-IPO.

IPOX® CEO Josef Schuster was interviewed by Reuters on the IPO (Read Here).

CMES (Ticker: 475400.KS) is a company in the optical equipment manufacturing industry, specializing in 3D vision-based intelligent robot solutions and 3D inspection technologies. The company provides automation solutions for logistics and manufacturing industries, using high-speed, high-precision 3D image processing and AI-driven robot control systems.

CMES will list on October 24, 2024, on the KOSDAQ market in South Korea. The firm is offering 2,600,000 shares at an expected price range of KRW 20,000 to 24,000 per share. The total offer size is KRW 52 billion (USD 38.52 million). The offering is managed by Samsung Securities, Eugene Investment & Securities, and Yuanta Securities.

Horizon Robotics (Ticker: 9660.HK) is a Chinese technology company specializing in advanced driver assistance systems (ADAS) and autonomous driving (AD) solutions for passenger vehicles, powered by its proprietary AI chips. Headquartered in Beijing, the company was founded in 2015 by former Baidu employees, including Yu Kai, and has secured investments from major backers such as Intel, Volkswagen Group, and Hillhouse Investment.

Horizon Robotics will list on the Hong Kong Stock Exchange (HKEX) on October 24, 2024. The company is offering shares to raise approximately HKD 5.27 billion (USD 672.89 million), with an expected market capitalization at the offer of HKD 50.71 billion (USD 6.47 billion). The IPO is managed by Morgan Stanley Asia Limited, Goldman Sachs (Asia) L.L.C., and China Securities (International) Corporate Finance Company Limited.

ADNH Catering (Ticker: ADNH UH) is a food and support services provider based in the UAE. The company offered 900 million shares, representing 40% of its total issued share capital, at a price of Dh0.96 per share in its initial public offering (IPO), raising Dh864 million ($235 million). ADNH Catering's market capitalization at listing is expected to be Dh2.16 billion ($588 million).

Shares will begin trading on the Abu Dhabi Securities Exchange (ADX) on October 23, 2024. The IPO was managed by Citigroup Global Markets and First Abu Dhabi Bank as Joint Global Coordinators, with additional UAE banks acting as bookrunners and receiving banks.

Tokyo Metro Co., Ltd. (Ticker: TBD) is a Japanese railway operator that manages Tokyo's subway system. Tokyo Metro will list on the Tokyo Stock Exchange on October 23, 2024. The company is offering shares at an indicative price of 1,100 yen, aiming to raise 319.55 billion yen (USD 2.23 billion). The expected market capitalization at the time of the offering is 639.1 billion yen (USD 4.44 billion).

The central government and the Tokyo government, which together hold 100% of Tokyo Metro, plan to sell half of their shares. Proceeds from the sale will be used to repay reconstruction bonds from the 2011 earthquake. The offering is managed by Goldman Sachs, Mizuho, and Nomura.

China Resources Beverage (Ticker: 2460.HK), the division of China Resources responsible for non-alcoholic beverages, primarily manufactures and distributes packaged drinking water under the brand C'estbon, along with other products like tea and coffee. Headquartered in Shenzhen, the company also operates regional offices in cities such as Beijing, Chengdu, and Shanghai.

China Resources Beverage will list on the Hong Kong Stock Exchange (HKEX) on October 23, 2024. The firm is offering shares to raise approximately HKD 4.91 billion (USD 626.43 million). The expected market capitalization at the offer is HKD 33.15 billion (USD 4.23 billion). The IPO is managed by BOCI Asia Limited, Merrill Lynch (Asia Pacific) Limited, UBS Securities Hong Kong Limited, and CITIC Securities (Hong Kong) Limited.

Hyundai Motor India Limited (Ticker: Pending) is a subsidiary of Hyundai Motor Group, manufactures and sells passenger vehicles and parts in India, including popular models like sedans, hatchbacks, SUVs, and electric vehicles (EVs).

The company is set to launch an IPO on October 22, 2024, listing on the Indian BSE and NSE. This IPO is an offer for sale of 142.19 million shares, priced between ₹1,865 and ₹1,960 per share, aiming to raise ₹27,870.16 crore (USD 3.32 billion). The offering is managed by Kotak Mahindra Capital, Citigroup Global Markets, HSBC, J.P. Morgan, and Morgan Stanley.

Intermestic Inc. (Ticker: 262A.T) is a Japan-based company engaged in the manufacturing and sales of eyewear, lenses, and accessories, including imports. The company will list on the Tokyo Stock Exchange Prime Market on October 18, 2024.

Intermestic Inc. is offering 7.88 million new shares along with 2.84 million existing shares at ¥1,630 per share. The total offer size is ¥17.16 billion (approximately $116.09 million USD). The estimated post-IPO market capitalization is ¥49.88 billion (around $337.38 million USD). The IPO is managed by SMBC Nikko, with Nomura, Mizuho, and Rakuten Securities.

YJ Link (Ticker: 209640.KS) is a company in the manufacturing of special-purpose machinery, specializing in surface-mount technology (SMT) equipment used in the assembly and testing of printed circuit boards (PCBs) for electronics production. The company provides automation solutions like PCB routers, loaders, and marking systems for efficient manufacturing processes.

YJ Link will list on October 18, 2024, on the KOSDAQ market in South Korea. The firm is offering 3,560,000 shares at a confirmed price of KRW 12,000 per share. The total offer size is KRW 42.72 billion (USD 31.64 million). The offering is managed by KB Securities.

Zabka Polska Sp z o o  (Ticker: n/a) is a Polish convenience store chain and one of the largest in Europe. The company is set to list on the Warsaw Stock Exchange on or around October 17, 2024. Zabka is selling 300 million shares at a price of 21.50 zlotys ($5.48) per share, raising 6.45 billion zlotys ($1.64 billion). If the overallotment option is fully exercised, the offer size will increase to 7.42 billion zlotys ($1.89 billion). The IPO values the company at 21.5 billion zlotys ($5.48 billion). Goldman Sachs and JPMorgan are serving as global coordinators for the offering.

Qiniu Ltd. (Ticker: 2567.HK) is an internet services and infrastructure company that provides Platform-as-a-Service (PaaS) solutions, focusing on one-stop audiovisual cloud services for enterprise customers. The company operates primarily in China.

Qiniu Ltd. is scheduled to list on The Stock Exchange of Hong Kong Limited (Main Board) on October 16, 2024. The firm is offering 15,975,000 shares at an offer price of HKD 2.74-2.86 per share, with an expected market capitalization of approximately USD 719.85 million at offer. The total offer size is USD 57.59 million. The IPO is being managed by BOCOM International (Asia) Limited and Shenwan Hongyuan Capital (H.K.) Limited, alongside several underwriters including Huatai Financial Holdings and GF Securities.

Nihon Suido Consultants Co., Ltd. (Ticker: 261A) is a construction consulting firm specializing in water infrastructure, with a focus on drinking and wastewater systems. The company will list on October 16, 2024, on the Standard market in Japan.

Nihon Suido Consultants is offering 5,245,300 shares, all of which are existing shares, at an offer price of ¥1,430 per share. The expected market capitalization at the time of the offering is ¥17.1 billion (USD 114.54 million). The total offer size is ¥7.5 billion (USD 50.63 million). The offering is managed by Nomura Securities.

Camp4 Therapeutics Corp. (Ticker: CAMP) is a clinical-stage biopharmaceutical company focused on developing RNA-based therapeutics to upregulate gene expression for treating genetic diseases. Its lead product candidate, CMP-CPS-001, aims to be the first disease-modifying therapy for urea cycle disorders (UCDs), a group of severe metabolic diseases. The company is also advancing treatments for SYNGAP1-related disorders using its RAP platform.

Camp4 Therapeutics will list on October 11, 2024, on NASDAQ. The firm is offering 5 million shares at a price range of $14.00 to $16.00. The expected market capitalization at offer is $265.28 million. The total offer size is approximately $75 million. The offering is managed by J.P. Morgan, Leerink Partners, Piper Sandler, and William Blair.

alt Inc. (Ticker: 260A.T) is a communications company engaged in the research and development of digital clone P.A.I. technologies, including products like AI Gijiroku and other AI solutions. alt Inc. will list on October 11, 2024, on the Growth market in Japan.

The company is offering 9,000,000 shares, including 7,500,000 new shares and 1,500,000 existing shares, at an offer price of ¥540 per share. The expected market capitalization at the time of the offering is ¥14.9 billion (USD 94.21 million). The total offer size is ¥4.86 billion (USD 32.81 million). The offering is managed by Daiwa Securities.

Ceribell Inc. (Ticker: CBLL) is a commercial-stage medical technology company focused on diagnosing and managing serious neurological conditions, particularly seizures. The company developed the Ceribell System, an EEG platform that combines portable hardware with AI-powered algorithms to provide rapid, point-of-care diagnosis and continuous monitoring of patients at risk of seizures in acute care settings. As of June 30, 2024, the Ceribell System has been used in over 100,000 patients across 450 healthcare facilities.

Ceribell will list on October 11, 2024, on NASDAQ. The company is offering 6.7 million shares at a price range of $14.00 to $16.00, with a total offer size of approximately $100.5 million. The expected market capitalization at the offer is $451.69 million. The offering is managed by BofA Securities and J.P. Morgan, with co-managers William Blair, TD Cowen, and Canaccord Genuity.

UpStream Bio Inc. (Ticker: UPB) is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with a focus on severe respiratory disorders such as asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company’s lead product candidate, verekitug, is a monoclonal antibody targeting the TSLP receptor, which plays a role in inflammatory responses. UpStream Bio plans to advance this drug through Phase 2 trials for asthma and CRSwNP, with additional development planned for COPD.

UpStream Bio will list on October 10, 2024, on NASDAQ. The firm is offering 12.5 million shares at a price range of $15.00 to $17.00. The expected market capitalization at the offer is $781.47 million. The total offer size is estimated at $200 million. The offering is being managed by JPMorgan, TD Cowen, Piper Sandler, and William Blair.

KinderCare Learning Companies, Inc. (Ticker: KLC) is the largest private provider of early childhood education in the United States by center capacity. The company serves children from six weeks to 12 years of age across a network of 1,500 centers and nearly 650 before- and after-school sites in 40 states and the District of Columbia.

KinderCare will list on October 9, 2024, on the NYSE. The firm is offering 24.0 million shares at a price range of $23.00 to $27.00. The expected market capitalization at offer is $2.86 billion. The total offer size is estimated at $600 million. The offering is managed by Goldman Sachs, Morgan Stanley, Barclays, J.P. Morgan, and others.

Zhejiang Taimei Medical Technology Co., Ltd. (Ticker: 2576.HK) is a medical and aesthetic services company providing digital solutions for pharmaceutical and medical device research, development, and commercialization in China and certain overseas markets. Zhejiang Taimei Medical Technology will list H Shares on the Hong Kong Stock Exchange (HKEX) on October 8, 2024.

The company is offering shares at a price range of HKD 10.00 to HKD 13.00. The expected market capitalization at the offer is HKD 5.60 billion to HKD 7.29 billion (USD 828.75 million). The total offer size is USD 33.15 million. The offering is managed by Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities Limited, along with other underwriters.